EphA4, which is a member of the large Eph (erythropoietin-producing hepatocellular carcinoma) family of receptor tyrosine kinases, has been shown to play oncogenic and tumour-suppressive roles in many human tumours [19, 20]. The gene discussed is EPHA4; the disease is neoplasm.